The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease

Journal of Nutrition

Volumn 132, Issue 5, 2002, Pages

  Feldman, Elaine B ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Life Sciences Research Office   (United States)

Author keywords

Coronary heart disease; Legumes; Nuts; Polyunsaturated fatty acids; Walnuts

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VEGETABLE OIL;

CARDIOVASCULAR RISK; CORONARY RISK; FAT INTAKE; FOOD COMPOSITION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; NONHUMAN; REVIEW; RISK MANAGEMENT; VEGETABLE; WALNUT;

JUGLANDACEAE; JUGLANS;

EID: 0036251717     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.5.1062s     Document Type: Review

References (144)

1. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
2. Inhibition of fibrinolysis by lipoprotein(a)
3. Conclusions from the VA-HIT Study
4. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
5. Epidemiology of hypertriglyceridemia and cardiovascular disease
6. A prospective study of triglyceride level, low-density lipoprotein particles diameter, and risk of myocardial infarction
7. Cardiovascular disease - Prevention by diet
8. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study
9. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel II)
10. Biochemical correlates of plaque progression and coronary events
11. Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association
12. Food labeling: Health claims; oats and coronary heart disease; Final rule
13. Cholesterol-lowering effects of dietary fiber: A meta-analysis
14. Dietary fat consumption and health
15. Dietary glycemic index and obesity
16. AHA dietary guidelines. Revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association
17. Fish consumption and risk of sudden cardiac death
18. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest
19. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes
20. n-3 Fatty acids and serum lipoproteins: Human studies
21. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease
22. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation
23. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: The EURAMIC Study
24. Frequent nut consumption and risk of coronary heart disease in women: Prospective cohort study
25. Mediterranean alphalinolenic acid-rich diet in secondary prevention of coronary heart disease
26. A clinical trial of the effects of dietary patterns on blood pressure
27. The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial
28. A dietary approach to prevent hypertension: A review of the Dietary Approaches to Stop Hypertension (DASH) Study
29. Effects of dietary patterns on blood pressure
30. Food labeling: Health claims; plant sterol/stanol esters and coronary heart disease; Interim final rule
31. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women
32. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
33. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
34. Homocyst(e)ine, diet, and cardiovascular diseases. A statement for healthcare professionals from the Nutrition Committee, American Heart Association
35. Homocysteine and cardiovascular risk
36. Homocysteine and cardiovascular disease: Cause or effect?
37. The controversy over homocysteine and cardiovascular risk
38. 6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease
39. Plasma homocst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease
40. Design of Physicians' Health Study II - A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials
41. Antioxidants for vascular disease
42. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data
43. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
44. Vitamin C status and mortality in US adults
45. "The SU.VI.MAX Study": A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers
46. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States
47. Dietary antioxidants and risk of myocardial infarction in the elderly: The Rotterdam Study
48. Fat and other lipids
49. Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-1
50. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects
51. Influence of polyunsaturated and saturated fats on plasma lipids and lipoproteins in man
52. Lack of effect of linoleic acid on the high-density-lipoprotein-cholesterol fraction of plasma lipoproteins
53. The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial
54. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis
55. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve year clinical trial in men and women
56. Effects on n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia
57. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects
58. New biological and clinical roles for the n-6 and n-3 fatty acids
59. A new relationship between total/high density lipoprotein cholesterol and polyunsaturated fatty acids
60. Recent advances in the biology of n-6 fatty acids
61. Safety considerations of polyunsaturated fatty acids
62. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet
63. Quantitative effects of dietary fat on serum cholesterol in man
64. Blood pressure, dietary fats, and antioxidants
65. Does dietary linolenic acid influence blood pressure?
66. Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies
67. Polyunsaturated fatty acids and platelet aggregation
68. Comparison between dietary monounsaturated and polyunsaturated fatty acids as regards diet-related diseases
69. Dietary lipids and blood cholesterol: Quantitative meta-analysis of metabolic ward studies
70. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials
71. Monounsaturated versus polyunsaturated dietary fat and serum lipids: A meta-analysis
72. Effects of walnuts on serum lipid levels and blood pressure in normal men
73. Food labeling: Health claims; oats and coronary heart disease; Proposed rule
74. Food labeling: Health claims; soy protein and coronary heart disease; Proposed rule
75. Food labeling: Health claims; soy protein and coronary heart disease; Final rule
76. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol
77. A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects
78. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women: A randomized crossover trial
79. Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia
80. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - The Jerusalem Nutrition Study: High MUFAs vs high PUFAs
81. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: Evidence from epidemiologic studies
82. Nut consumption, lipids, and risk of a coronary event
83. Does nut consumption protect against ischaemic heart disease?
84. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist health study
85. Effect of risk factor values on lifetime risk of and age at first coronary event: The Adventist health study
86. Association among health habits, risk factors, and all-cause mortality in a black California population
87. Risk factors for all-cause and coronary heart disease mortality in the oldest-old. The Adventist Health Study
88. Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists
89. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
90. Walnuts and serum lipids [letter re: Sabaté et al. "Effects of walnuts on serum lipid levels blood pressure in normal men." Engl. J. Med. 1993. 328: 603-607]
91. Dietary intake of a-linolenic acid and risk of fatal ischemic heart disease among women
92. Nut consumption and the risk of sudden and total cardiac death in the physicians health study
93. Blood cholesterol and walnut consumption: A cross-sectional survey in France
94. Essential fatty acids and cardiovascular disease: The Edinburgh Artery Study
95. Serum fatty acids and the risk of stroke
96. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT)
97. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study
98. The traditional and emerging role of nuts in healthful diets
99. California walnuts: The natural way to a healthier heart
100. California walnuts and light foods
101. Fatty acid content of New Zealand-grown walnuts (Juglans regia L.)
102. Variation in polyunsaturated fatty acids composition of Persian walnut
103. Studies on glycolipids of Kenaf, English Walnut, Myrobalan and Manila Tamarind seeds of the Vidarbha region (India)
104. Volatile constituents of the essential oil of the peels of Juglans nigra L
105. Effect of geographic origin, variety and storage on tocopherol concentrations in walnuts by HPLC
106. Total dietary fiber content of selected nuts by two enzymatic-gravimetric methods
107. Inhibitory effect of nuts on iron absorption
108. The composition and concentration of n-alkanes in retail samples of edible oils
109. Use of antioxidants in extraction of tannins from walnut plants
110. Distribution of 5-hydroxy-1, 4-naphthoqinone and other napthoquinone derivatives in the Juglandaceae (walnut family) and related families
111. Effects of walnuts on the serum lipid profile of hypercholesterolemic subjects: The Barcelona walnut trial
112. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans
113. Nuts and plasma lipids: An almond-based diet lowers LDL-C while preserving HDL-C
114. Effects of almonds on serum lipids and fasting glucose levels in normocholesterolemic subjects
115. Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts
116. Effects of a macadamia nut enriched diet on serum lipids and lipoproteins compared to a low fat diet
117. Effects of diets high in monounsaturated fatty acids on plasma LDL subclasses in healthy men and women: Macadamia Nut Study - Phase II
118. Effect of pistachio nuts on serum lipid levels in patients with moderate hypercholesterolemia
119. Effect of pecan rich diet on serum lipids and lipoproteins in healthy men and women
120. Effect of pecan consumption on stool fat
121. Nuts and their bioactive constituents: Effects on serum lipids and other factors that affect disease risk
122. Low fat-monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles
123. Low-fat, monounsaturate-rich diets reduce susceptibility of low density lipoproteins to peroxidation ex vivo
124. Effect of a diet high in vegetables, fruit, and nuts on serum lipids
125. An Indian experiment with nutritional modulation in acute myocardial infarction
126. Effects of dietary protein and carbohydrate on plasma cholesterol levels in relation to atherosclerosis
127. Atherogenicity of animal and vegetable protein. Influence of the lysine to arginine ratio. [letter re: Weigensberg et al. "Effect of lysine deficiency on cholesterol atherosclerosis in rabbits." Exp. Mol. Path. (1964) 3: 444]
128. Comparaison chez le lapin des proprietes nutritionnelles et hypocholesterolemiantes du tourteau de noix a celles du tourteau de soja et de la caseine
129. Effects of varying dietary proteins on plasma lipids and rabbit platelet function
130. Action d'huiles polyinsaturees (noix et maïs) sur quelques parametres lipidques du serum et I'agregation plaquettaire du lapin
131. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
132. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men
133. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans
134. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
135. Nitric oxide and vascular disease
136. Dietary arginine and the prevention of cardiovascular diseases
137. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - The Jerusalem nutrition study. II. Monounsaturated fatty acids vs carbohydrates
138. Effect of a diet high in monounsaturated fat from almonds on plasma cholesterol and lipoproteins
139. Diet as primordial prevention in Seventh-Day Adventists